
TVGN Stock Forecast & Price Target
TVGN Analyst Ratings
Bulls say
Tevogen is facing potential near-term trading pressure as it implements a reverse stock split, which may be perceived negatively by the market. This action also reflects a weaker position in the capital markets, resulting in a downgrade from Buy to Hold by financial analysts. As a result of this downgrade, the previous price target of $5.0 has been removed and lowered to $2.0.
Bears say
Tevogen is facing significant risk factors such as clinical and regulatory risks, partnership and financial risks, commercial risks, and legal and intellectual property risks. In addition, the recent reverse stock split may negatively impact the company's existing shareholder base and create reduced liquidity, a shrinking shareholder base, and selling pressure in the near future. Furthermore, the company's decreasing revenue from milestone and royalty sources is concerning for future growth and profitability.
This aggregate rating is based on analysts' research of Semper Paratus Acquisition Corp and is not a guaranteed prediction by Public.com or investment advice.
TVGN Analyst Forecast & Price Prediction
Start investing in TVGN
Order type
Buy in
Order amount
Est. shares
0 shares